Jerome Zeldis
2017 - Sorrento Therapeutics
In 2017, Jerome Zeldis earned a total compensation of $464K as Chief Medical Officer and President of Clinical Development at Sorrento Therapeutics, a 52% decrease compared to previous year.
Compensation breakdown
| Option Awards | $189,000 |
|---|---|
| Salary | $275,011 |
| Total | $464,011 |
Zeldis received $275K in salary, accounting for 59% of the total pay in 2017.
Zeldis also received $189K in option awards.
Rankings
In 2017, Jerome Zeldis' compensation ranked 12,111th out of 14,666 executives tracked by ExecPay. In other words, Zeldis earned more than 17.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,111 out of 14,666 | 17th |
Division Manufacturing | 4,774 out of 5,772 | 17th |
Major group Chemicals And Allied Products | 1,747 out of 2,075 | 16th |
Industry group Drugs | 1,447 out of 1,731 | 16th |
Industry Biological Products, Except Diagnostic Substances | 264 out of 313 | 16th |
Source: SEC filing on July 19, 2018.
Zeldis' colleagues
We found four more compensation records of executives who worked with Jerome Zeldis at Sorrento Therapeutics in 2017.